ST交投(002200.SZ):聯合體中標瀾滄至孟連(勐阿)高速公路瀾滄至孟連段工程特許經營項目社會投資人招標(三次)
格隆匯8月2日丨ST交投(002200.SZ)公佈,公司於近日收到招標代理機構雲南雲嶺工程造價諮詢有限公司發來的《中標通知書》,經公開招投標,公司參與的聯合體被確定為“瀾滄至孟連(勐阿)高速公路瀾滄至孟連段工程特許經營項目社會投資人招標(三次)”項目的中標人。
項目總投資91.40億元,公司作為聯合體成員之一,主要負責項目中的綠化與環境保護工程部分,預計實施份額約為總投資的0.7%至1.5%。具體實施份額公司還將參與聯合體內部競爭報價程序確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.